Advocating for People living with Scleroderma
Join our community of advocates today!

Advocating for People living with Scleroderma

As the leading patient advocacy organization in the US for people impacted by scleroderma, National Scleroderma Foundation leadership is closely monitoring the current political climate, including actions coming from the White House. We anticipate we will need the united attention and action of our entire community in the coming months and years. Be sure to sign up for our advocacy alerts at https://scleroderma.org/take-action/ to receive time-sensitive announcements email when it’s time to take action and reach out to members of Congress about a vote or sponsorship of a bill that impacts people affected by scleroderma.

We remain committed to maximizing the impact we can have on complex issues facing those living with scleroderma, their families and support networks as well as the medical and scientific communities.

Our leadership will continue lead with integrity and steward a community in which everyone can share openly and engage authentically.?

Health and Human Services?

The Office of Management and Budget (OMB) issued a memo freezing operations at the National Institutes of Health (NIH), Food and Drug Administration (FDA), and Centers for Disease Control and Prevention (CDC). The results of this action included the cancellation of grant reviews and council meetings, at-will NIH leadership put under review for dismissal, programs removed from the NIH website, NIH officers being placed on indefinite administrative leave, and the freezing of all new awards.

Research America! has created a?helpful resource?with a detailed timeline of events surrounding the funding freeze.

Updates?

?Take Action!?

  • Leaders of the House and Senate Appropriations Committees have started discussions on revised topline spending levels for FY25 appropriations. This is a promising step toward avoiding a year-long extension of flat funding and — with our advocacy — achieving increased research funding.?Take action now by customizing this?email?to share your voice directly with your members of Congress.
  • We are also?continuing to engage with our champions?to ensure that as they wrap up FY25 appropriations, our key items continue to be included such as inclusion of scleroderma in the Department of Defense's Peer-Reviewed Medical Research Program and funding for key agencies such as the NIH and CDC. ?

Health Policy Extenders

The March 14 government funding deadline is rapidly approaching. If a bipartisan deal is not reached, a government shutdown is inevitable. It is critical that we engage Members of Congress to emphasize the importance of?key health policy extenders (a full list of health provisions can be found in Division C, Titles I and II, of the?American Relief Act, 2025),?as well as the importance of?reauthorizing other important, R&D-relevant legislation that did not make into the package of health extenders referenced above, including the?Rare Pediatric Disease Priority Review Voucher Program.?

Take Action!?

The best way to reach your elected officials in the House and in the Senate is to call the U.S. Capitol Switchboard at (202) 225-3121. An operator will connect you to your Representative or Senator’s office. If you don’t know who your representative and/or senators are, follow these links for helpful search tools.

Find Your Senators?Find Your Representative

Community Engagement?

Last week, we hosted our first?#TealTalk?of the year, focused on advocacy. You can view a recording on our YouTube channel at?https://www.youtube.com/watch?v=_C4aOvppDhs.?

Please reach out to [email protected] or (800) 722-HOPE [4673] for information and resources along the way.?

Please note, the Foundation is a nonpartisan organization. Regardless of our individual personal beliefs or political affiliations, we must maintain strong working relationships with both sides of the aisle for continued advocacy success for our community.?Thank you for your continued advocacy and support!?


要查看或添加评论,请登录

Mary Wheatley, IOM, CAE的更多文章

  • A Busy Spring Ahead | CEO Update: March 2025

    A Busy Spring Ahead | CEO Update: March 2025

    Advocating for the Scleroderma Community As the leading scleroderma patient advocacy organization in the US, National…

  • Maximizing Our Impact in 2025

    Maximizing Our Impact in 2025

    As anticipated when a new administration fully launches, there has been much activity in the last two weeks. Foundation…

  • Happy New Year! January CEO Update

    Happy New Year! January CEO Update

    As we ring in the new year, it's a time for reflection and fresh beginnings. Last year was filled with moments of…

  • Celebrating the Power of Associations

    Celebrating the Power of Associations

    Yesterday, I had the tremendous honor of accepting the Clifford M. Clarke Award.

    33 条评论
  • Winter Happenings at the Foundation: CEO Update December 2024

    Winter Happenings at the Foundation: CEO Update December 2024

    GivingTuesday is Here! Amgen Rare Disease is generously offering a $25,000 match for GivingTuesday. Don’t wait—make…

  • Scleroderma community gathers at #ACR24

    Scleroderma community gathers at #ACR24

    The National Scleroderma Foundation team is just returning from the 2024 ACR Convergence Meeting in Washington, DC. At…

    2 条评论
  • Come see us at Convergence!

    Come see us at Convergence!

    Are you attending ACR Convergence 2024 in Washington, D.C.

    2 条评论
  • Building a Foundation for the Future

    Building a Foundation for the Future

    National Scleroderma Foundation Board Vice Chair Carol Feghali-Bostwick and I had the opportunity to participate in the…

    3 条评论
  • Fall Happenings at the Foundation: November CEO Update

    Fall Happenings at the Foundation: November CEO Update

    Save the date for GivingTuesday, December 3. 2024! We’re thrilled to announce that, for the second year in a row, our…

  • CEO Update: October 2024

    CEO Update: October 2024

    Outreach We are attending CHEST in Boston October 6-9. If you or anyone from your team are attending, please let us…

社区洞察

其他会员也浏览了